menu
    • menu

    Company profile for Micron Biomedical

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Micron develops pharmaceutical products, based on its microneedle patch technology, that are designed to provide enhanced protective (vaccine) and therapeutic (drugs) effects, superior patient compliance, and simplified administration, distribution, and storage logistics.The benefits of Micron’s microneedle patch technology stem from its proprietary design and manufacturing which allow for: Skin-based targeting and delivery...
    Micron develops pharmaceutical products, based on its microneedle patch technology, that are designed to provide enhanced protective (vaccine) and therapeutic (drugs) effects, superior patient compliance, and simplified administration, distribution, and storage logistics.The benefits of Micron’s microneedle patch technology stem from its proprietary design and manufacturing which allow for: Skin-based targeting and delivery of actives Painless administration and elimination of needle phobia

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Micron BiomedicalUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    575 Fourteenth Street, NW Suite 100 Atlanta, GA 30318
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://micronbiomedical.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Micron Biomedical Appoints Dr. Jayne Morgan to Board of Advisors
    Micron Biomedical Appoints Dr. Jayne Morgan to Board of Advisors

    09 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/09/3095930/0/en/Micron-Biomedical-Names-Health-Education-and-Empowerment-Advocate-Dr-Jayne-Morgan-to-Board-of-Advisors.html

    GLOBENEWSWIRE
    09 Jun 2025
    Share Share
    Micron Biomedical Secures $33M+ To Develop Needle-Free Therapeutics
    Micron Biomedical Secures $33M+ To Develop Needle-Free Therapeutics

    16 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/16/3010684/0/en/Micron-Biomedical-Extends-Series-A-Financing-to-33-Million-to-Accelerate-Commercialization-of-Needle-Free-Therapeutics-and-Vaccines.html

    GLOBENEWSWIRE
    16 Jan 2025
    Share Share
    Micron Biomedical Wins BARDA Prize For Needle-Free mRNA Flu Vaccine
    Micron Biomedical Wins BARDA Prize For Needle-Free mRNA Flu Vaccine

    14 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/14/3009591/0/en/UPDATE-Micron-Biomedical-Wins-2-Million-BARDA-Competition-for-Its-Collaboration-with-Zipcode-Bio-to-Develop-mRNA-Based-Broad-Protecting-Flu-Vaccine-Without-Needles.html

    GLOBENEWSWIRE
    14 Jan 2025
    Share Share
    Micron Biomedical Wins $2M BARDA Grant For Needle-Free Flu Vaccine
    Micron Biomedical Wins $2M BARDA Grant For Needle-Free Flu Vaccine

    13 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/13/3008857/0/en/Micron-Biomedical-Wins-2-Million-BARDA-Competition-for-Its-Collaboration-with-Zipcode-Bio-to-Develop-mRNA-Based-Broad-Protecting-Flu-Vaccine-Without-Needles.html

    GLOBENEWSWIRE
    13 Jan 2025
    Share Share
    CEPI & Micron Get $3.7M Grant For Needle-Free Vaccine Development
    CEPI & Micron Get $3.7M Grant For Needle-Free Vaccine Development

    08 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/08/3006117/0/en/CEPI-and-Micron-Biomedical-Accelerate-Needle-Free-Vaccines-against-Disease-X-with-3-7-Million-Grant-to-Advance-Learnings-from-COVID-19.html

    GLOBENEWSWIRE
    08 Jan 2025
    Share Share
    Micron Secures $43M Grant To Advance Needle-Free Vaccine Tech
    Micron Secures $43M Grant To Advance Needle-Free Vaccine Tech

    07 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/07/3005212/0/en/Micron-Biomedical-Secures-43-Million-in-Total-Grant-Support-to-Improve-Coverage-of-Measles-and-Rubella-Vaccine-and-Accelerate-World-s-First-Phase-2-Trial-of-Needle-Free-Drug-and-Va.html

    GLOBENEWSWIRE
    07 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search